These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3100727)

  • 1. Phase II clinical trial of triazinate in combination with mitomycin C for patients with advanced gastric cancer.
    O'Connell MJ; Schutt AJ; Moertel CG; Hahn RG
    J Clin Oncol; 1987 Jan; 5(1):83-5. PubMed ID: 3100727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the Pan American Health Organization.
    Ahlgren JD; Smith FP; Cazap E; Estevez RA; Marantz A; Woolley PV; Wilcosky T; Stein J; Schein PS
    Cancer Treat Rep; 1987 Apr; 71(4):419-20. PubMed ID: 3548959
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of advanced gastric carcinoma with mitomycin and doxorubicin.
    Dalley D; Erlichman C; Fine S
    Cancer Treat Rep; 1986 Jul; 70(7):897-8. PubMed ID: 3719582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A combined chemotherapy with UFT and mitomycin C in advanced gastric cancer; report of 2 cases].
    Nakata K; Shigemitsu M; Joya K; Sato K; Hara S; Hanawa S
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1694-6. PubMed ID: 3927850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A markedly effective combination therapy of 5'-DFUR and MMC in advanced gastric cancer--a case report].
    Watanabe S; Mayama M; Oguro M; Wakatsuki S; Majima H
    Gan To Kagaku Ryoho; 1990 Oct; 17(10):2105-8. PubMed ID: 2145807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-randomized comparison between irinotecan plus mitomycin C and irinotecan alone in patients with advanced gastric cancer refractory to fluoropyrimidine and platinum.
    Ueda A; Hosokawa A; Ogawa K; Yoshita H; Mihara H; Ando T; Kajiura S; Fujinami H; Nishikawa J; Minemura M; Terada M; Kobayashi T; Horikawa N; Yabushita K; Note M; Sugiyama T
    Anticancer Res; 2013 Nov; 33(11):5107-11. PubMed ID: 24222156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of irinotecan and mitomycin C in 5-fluorouracil-pretreated patients with advanced colorectal and gastric cancer.
    Bamias A; Papamichael D; Syrigos K; Pavlidis N
    J Chemother; 2003 Jun; 15(3):275-81. PubMed ID: 12868555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)".
    Flechtner H; Queisser W; Heim ME; Henss H; Arnold H; Fritze D; Herrmann R; Fritsch H; Fritz M; Trux FA
    Onkologie; 1987 Apr; 10(2):67-71. PubMed ID: 3108738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
    De Lisi V; Cocconi G; Angelini F; Cavicchi F; Di Costanzo F; Gilli G; Rodinò C; Soldani M; Tonato M; Finardi C
    Cancer; 1996 Jan; 77(2):245-50. PubMed ID: 8625230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of an aged woman with advanced gastric cancer which dramatically responded to combined chemotherapy with UFT and mitomycin C].
    Adachi M; Sasaki M
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2856-7. PubMed ID: 3092746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
    Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined UFTM for 140 patients with advanced gastric cancer].
    Jin ML
    Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):130-2. PubMed ID: 2553364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of sequential chemotherapy and low-dose radiotherapy in advanced gastric adenocarcinoma. A Southwest Oncology Group Pilot Study.
    Bukowski RM; Theodors A; Purvis JD; Budd GT; Weick JK; Gahbauer R
    Am J Clin Oncol; 1987 Oct; 10(5):376-9. PubMed ID: 3661488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277).
    Douglass HO; Lavin PT; Goudsmit A; Klaassen DJ; Paul AR
    J Clin Oncol; 1984 Dec; 2(12):1372-81. PubMed ID: 6439836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer.
    Park KW; Ahn JS; Park YS; Lee J; Kang JH; Park JO; Lim HY; Im YH; Kang WK; Park K; Lee SI
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):17-21. PubMed ID: 16721549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug combinations in the treatment of gastric adenocarcinoma: a randomized Southwest Oncology Group study.
    Panettiere FJ; Haas C; McDonald B; Costanzi JJ; Talley RW; Athens J; Oishi N; Heilbrun LK; Chen TT
    J Clin Oncol; 1984 May; 2(5):420-4. PubMed ID: 6427416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternating chemotherapy in advanced gastric cancer. A phase II study.
    Feliu J; Girón CG; González-Baron M; Berrocal A; Barón-Saura JM
    Cancer Chemother Pharmacol; 1991; 28(4):313-4. PubMed ID: 1908751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C.
    Cunningham D; Soukop M; McArdle CS; Carter DC; Smyth JF; Allan SG; Kaye SB; Sangster G; Calman KC; Hutcheon AW
    Br J Surg; 1984 Sep; 71(9):673-6. PubMed ID: 6548166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination chemotherapy of advanced gastric cancer with adriamycin, mitomycin C, and ftorafur].
    Miyamoto H; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Ikeda K; Usui N; Nakada H; Okada Y
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1160-4. PubMed ID: 6408998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful treatment of advanced gastric cancer by combined cisplatinum, mitomycin C and 5-FU administration. A case report].
    Tanemura H; Kawata R; Suzuki M; Shimokawa K; Tsuya H; Ando T; Azuma S; Furuta T; Saji S; Ohashi H
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):728-31. PubMed ID: 3103542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.